医学
比伐卢定
肝素
肾脏替代疗法
体外
抗凝血酶
麻醉
内科学
心脏病学
心肌梗塞
经皮冠状动脉介入治疗
作者
Tyree H. Kiser,Robert MacLaren,Douglas N. Fish,Kathryn L. Hassell,Isaac Teitelbaum
标识
DOI:10.1592/phco.30.11.1117
摘要
Compared with heparin, bivalirudin was more efficacious in prolonging hemofilter survival time and was well tolerated. Additional studies of bivalirudin for prevention of hemofilter occlusion during continuous renal replacement therapy are warranted.
科研通智能强力驱动
Strongly Powered by AbleSci AI